Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged > 70 Years) and Octogenarians with Systolic Heart Failure
                        AuthID
P-00K-T5G
                
    P-00K-T5G
 
    
                     
    
                     
    
                     
                    